In what appears to be the worst news yet conerning any of the leading COVID-19 vaccine candidates, a volunteer enrolled in the trial for AstraZeneca’s COVID-19 vaccine candidate (which it’s working on with Oxford) has died.

Brazilian health authority Anvisa announced Wednesday that one of the volunteers who was participating in the study had died. The news sent the company’s ADRs to their lowest level since April, per Reuters.

AstraZeneca’s massive globe-spanning trial was put on mandatory hiatus back in September after two participants were sickened in the company’s trial in the UK, prompting authorities to close it down briefly.

However, the FDA refused to restart the trial in the US, citing vague safety-related criteria.

In a statement, a spokesperson from the University of Oxford, which is developing the vaccine with AstraZeneca, said “there have been no concerns about safety of the clinical trial” after an assessment of the case in Brazil.

We now await more information from AZ.

Republished from with permission

Sign up on or to check out our store on